Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer
Clinical trial NCT00387153 · TERMINATED
Trial details
- NCT number
- NCT00387153
- Sponsor
- Myriad Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2006-10-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.